The Art of Medicine: Clinical Considerations for Patients With Advanced RCC
Listen to Elizabeth R. Plimack, MD, MS; Brian A. Costello, MD; and Martin H. Voss, MD, discuss clinical management pearls for IO-based therapy in patients with renal cell carcinoma.
Decera Clinical Education Oncology Podcast · Brian A. Costello MD, Martin H. Voss MD, Elizabeth R. Plimack MD MS
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, an expert medical oncology panel led by Elizabeth R. Plimack, MD, MS, with Brian A. Costello, MD, and Martin H. Voss, MD, discusses clinical pearls for the management of patients with metastatic renal cell carcinoma (RCC). Topics include:
- Treating beyond progression with immunotherapy
- Management of patients with less common histologic subtypes of RCC
- Potential biomarkers for RCC
- Adverse event management
Presenters:
Elizabeth R. Plimack, MD, MS
Chief, Division of Genitourinary Medical Oncology
Director, Genitourinary Clinical Research
Professor, Department of Hematology/
Oncology
Fox Chase Cancer Center
Temple Health
Philadelphia, Pennsylvania
Brian A. Costello, MD
Associate Professor of Oncology and Urology
Division of Medical Oncology
Mayo Clinic
Rochester, Minnesota
Martin H. Voss, MD
Clinical Director, Genitourinary Medical Oncology Service
Memorial Sloan Kettering Cancer Center
Assistant Professor
Weill Cornell Medical College
New York, New York
Content based on an online CME program supported by educational grants from Eisai, Exelixis, and Pfizer and EMD Serono.
Link to full program:
https://bit.ly/32IS9gx
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.